Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy (NCT07119775) | Clinical Trial Compass
AVAILABLENot Applicable
Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy
Plain-language summary
This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.